2100 WHARTON STREET, PITTSBURGH, PA
Announces Second Quarter 2026 Financial and Operating Results
Other Events, Press Release
Krystal Biotech Elects Class III Directors at 2026 Annual Meeting
Announces First Quarter 2026 Financial and Operating Results
Annual Report to Security Holders
Announces Fourth Quarter and Full Year 2025 Financial and Operating Results
Provides Business Update at 44th Annual J.P. Morgan Healthcare Conference
Investor Presentation
Q2
Q1
FY 2024
Q3
FY 2023
Registration Statement for Securities to be Offered to Employees
S-3ASR
Prospectus filed pursuant to Rule 424(b)(5)
Prospectus Filed Pursuant to Rule 424(b)(2)
Definitive Proxy Statement
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Submission Upload
Correspondence
S-1MEF